Abstract
Although bariatric surgery is approved for a woman of child-bearing age with an interest in subsequent pregnancy, reports of in utero growth issues during pregnancy have garnered a closer look at the impact of maternal surgical weight loss on the pre- and postpartum periods. Offspring of dams having received vertical sleeve gastrectomy (VSG) are born small-for-gestational age and have increased risk for metabolic syndrome later in life. Here we aimed to determine whether the postnatal catch-up growth trajectory of bariatric offspring may be affected by milk composition. Milk samples were collected at postnatal day 15/16 from dams having received VSG surgery and fed a high-fat diet (HFD) (H-VSG), Sham surgery and fed chow (C-Sham) or Sham surgery and fed HFD (H-Sham). Milk obtained from H-VSG dams had elevated glucose (P < 0.05) and significantly reduced triglyceride content (P < 0.01). Milk from H-Sham dams had the lowest amount of milk protein (P < 0.05). Fatty acid composition measured by fractionation was largely not affected by surgery but rather maternal diet. No difference in milk leptin levels was observed, however insulin, adiponectin and growth hormone levels were significantly increased in milk from H-VSG animals. H-Sham had the lowest level of immunoglobulin (Ig)A whereas IgG was significantly reduced in H-VSG. Taken together, the quality of milk from H-VSG dams suggests that milk composition could be a factor in reducing the rate of growth during the lactation period.
Keywords: bariatric surgery, milk, obesity, hormones, nutrients
INTRODUCTION
Bariatric surgery is the most effective treatment for the reduction of the comorbidities of obesity and diabetes and its popularity is increasing. There are many positive benefits due to surgical weight loss procedures like Roux-en-Y gastric bypass (RYGB) and vertical sleeve gastrectomy (VSG) for both males and females; including loss of body weight and adiposity, improvements in plasma lipid profiles and reduced need for pharmacologic control of blood glucose1,2. Additionally, both result in similar changes in gut hormone secretion in humans3, rodents4, and comparable remission of type-2 diabetes in humans5,6.
Women are overwhelmingly the most common recipients (>80%) of bariatric surgery and approximately half are of child-bearing age7. In woman of child-bearing age, some additional reproductive improvements have been reported after obtaining bariatric surgery include: return of menstrual cycles8, recovery of luteal function9 and increased spontaneous (unassisted) pregnancies10. Furthermore, after successfully achieving pregnancy, women who have had bariatric surgery have a lower risk of gestational diabetes, gestational hypertension and preeclampsia11,12. Thus, women who undergo weight loss surgery have a significant health benefit for both the mother and child. Unfortunately, there are also numerous reports that highlight negative outcomes in women with previous bariatric surgery; including increased risk for small-for-gestational age babies or intrauterine-growth restriction12–14, preterm birth12, stillbirth and neonatal death11,15.
Though rodent models of bariatric surgery also tout many of the same improvements to metabolic health as reported in the human7,16–18, previously we reported that females that have received vertical sleeve gastrectomy (VSG) prior to pregnancy, have offspring that are born smaller and shorter, as well as experience catch-up growth during postnatal life7. During the first 15-16 days postnatal life, the rat pup is exclusively dependent on ingestion of maternal milk; independent food consumption begins around postnatal day 16 (PD16). Milk composition varies based on nutritional status of the dam and the diet consumed. Previously, studies have indicated that milk yield is reduced in a model of calorie restriction; with a more pronounced decrease occurring when dams are restricted both prior to and during lactation than those primarily restricted during lactation19,20.
In the present studies, we hypothesized that the VSG pups would have a reduced rate of growth and that this reduction was due to altered nutrient and hormone content of the milk. We probed whether milk obtained at PND15/16 from dams having received VSG prior to pregnancy and fed a high-fat diet (H-VSG) produced milk of a similar quality to either body weight-matched, chow-fed dams (C-Sham) or diet-matched, HFD-fed obese (H-Sham) dams. We analyzed the growth trajectory during postnatal life, milk macronutrient content, fatty acid composition and hormone levels.
METHODS
Animals:
All procedures for animal use were approved by the University of Cincinnati Institutional Animal Care and Use Committee. In the present study we report on lactating maternal body weights and food intake and milk samples collected from dams PND15-16. Other parameters of these females prior to their pregnancy and their offspring have been previously carefully reported7.
As previously reported7, adult female Long-Evan rats (Harlan Laboratories, Indianapolis, IN; 225-250 g) were individually housed and maintained in a room on a 12/12-h light/dark cycle at 25 °C and 50-60% humidity. Following acclimatization to the facilities, animals were given ad libitum access to water and either low-fat chow (#7012, Harlan Teklad, 3.41kcal/g; 5.67% fat) or palatable high-fat diet (HFD) (#D03082706, Research Diets, New Brunswick, NJ, 4.54 kcal/g; 41% fat) for 3 weeks prior to surgery. Animals were assigned in a counter balanced fashion to 3 groups: A) maintained on chow and having received Sham-VSG surgery (C-Sham), B) maintained on HFD and having received Sham-VSG (H-Sham), C) maintained on HFD and having received VSG surgery (H-VSG). The subset of dams used in the present study were previously characterized and contributed to the body of work on VSG pregnancy by Grayson et al7. In the current study, C-Sham, N=9, H-SHAM, N=7 and H-VSG, N=7 were used.
Surgery:
Animals received either Sham-VSG or VSG performed by trained surgical core as described7. Animals recovered on Osmolite OneCal Liquid diet for 3 d with postoperative saline and analgesics7. Animals were mated 5 weeks after surgery.
Husbandry:
As previously described7, singly-housed males were caged with one female for 4-8 d. Females were returned to their own cages for the remainder of gestation when a significant increase in body weight was measured. Parturition was designated as postnatal day 0 (PND0). Dams were allowed to suckle their own litters. Litters were culled to 4 females and 4 males (when possible) on PND2. Pups were weighed on PND2, 7, 14 and 21.
Milk collection:
On PND15-16 and 4h into the light cycle, pups were removed from the dams for 4h to increase milk reserves. After 4h, dams were anesthetized with isoflurane and injected intramuscularly with 0.6 units of purified oxytocin (Agrilabs, St Joseph, MO) to stimulate milk ejection. Milk samples were collected by vacuum pump and frozen at −20° C until further processing and analysis. Pups were returned to dams following the procedure.
Glucose determination:
Milk and blood glucose was measured in duplicate using an AccuChek glucometer with corresponding strips.
Protein albumin determination:
Concentrations were determined using a Pierce BCA protein assay kit (Thermo Scientific, Rockford, IL) and spectrometry was performed with a Tecan Infinite 200 PRO. A standard curve with known concentrations of albumin was used to extrapolate the milk protein concentration.
Free Fatty Acid Analysis:
Fatty acid analysis was performed at the Cincinnati Mouse Metabolic Phenotyping Center. A subset of milk samples, N=6/group, were submitted for fractionation. The Shimadzu GC-2010 gas chromatograph (GC) was used to detect methyl esters of free fatty acids. First, samples were saponified with methanolic sodium hydroxide to obtain free fatty acids. Next, fatty acids were methlyated with 14% BF3 methanol to produce fatty acid methyl esters (FAMES). Finally, FAMES were extracted in hexane, and this solution injected into the GC for analysis. Fatty acids were detected by the GC FID and a peak was formed on the monitor, indicating the presence of a specific fatty acid known to peak at that retention time point after injection. Quantitative analysis was also performed using an internal standard in each sample, which is a known amount of fatty acid normally not present in the sample (heptadecanoic acid -HDA).
Measurements of adipokines and analytes:
The following analytes were measured according to the manufacturer’s specifications: Infinity Cholesterol Reagent (#TR13421, ThermoFisher, VA), Infinity Triglyceride Reagent (#TR22421, ThermoFisher, VA), insulin (#90060, Crystal Chem, Downers Grove, IL), leptin (#MOB00, R & D System, Minneapolis, MD), adiponectin (#EZRADP-62K, EMD Millipore) and rat immunoglobulin (Ig)A (#6410-10, Alpha Diagnostic International) and IgG (#6420, Alpha Diagnostic International).
Statistical analyses:
All statistical analyses were performed using GraphPad Prism version 7.2 (GraphPad Software, San Diego, California, USA). Differences between 3 treatments were analyzed using 1-way analysis of variance (ANOVA) followed by Tukey’s post-hoc test. To observe time-wise differences, two-way ANOVA with repeated measures was performed using Treatment Group and Time as factors. Further analysis was performed to determine specific differences by Student t tests specifically because animals were body weight-matched or diet-matched. All results are given as means ± SEM. Results were considered statistically significant when P < 0.05.
RESULTS
VSG dams maintained on HFD (H-VSG) prior to and following surgery weighed significantly less than Sham dams maintained on HFD (H-Sham) on postnatal days 15-16 (PND15-16) (P < 0.01) (Figure 1A). Despite maintenance on diet of differing fat content, all 3 groups of animals ingested similar amounts of average calories during lactation (Figure 1B). Body weight curves for the male pups from the dams whose milk was extracted demonstrated that offspring of H-VSG (oH-VSG) have reduced body weight growth during postnatal life in comparison to oC-Sham and oH-Sham (P < 0.05) (Figure 1C). When the slope of the growth trajectory for the animals (Figure 1C) is calculated, H-VSG animals have a significantly reduced growth trajectory in comparison to both C-Sham and H-Sham (P < 0.001) (Figure 1D).
Figure 1. Dam and offspring weight and growth trajectory.

(A) Body weight of dams at PND16 (B) Average daily kCal intake of dams at PND15/16. (C) Body weight curve of offspring of dams from birth to PND21 (D) Calculation of the slope of the postnatal body weight curve of the offspring. Data is presented as Mean ±SEM, *P < 0.05, **P < 0.01, ***P < 0.001.
No difference was detected for glucose, protein, cholesterol or triglyceride content of the milk expressed from animals at PND15-16 by 1-way ANOVA (Figure 2A–D). However, elevated glucose concentrations were detected in H-VSG vs. C-Sham (t test, P < 0.05) (Figure 2A). Reduced protein concentrations were identified in H-Sham vs. H-VSG (t test, P < 0.05) (Figure 2B). Furthermore, H-VSG animals had significantly reduced triglyceride content in comparison to H-Sham animals (P < 0.01) (Figure 2D).
Figure 2. Macronutrients in milk from PND15/16 dams.

(A) Glucose in mg/dL (B) Protein albumin mg/dL (C) Cholesterol in mg/dL (D) Triglycerides in mg/dL. Data is presented as Mean ±SEM, *P < 0.05, **P < 0.01.
Total lipid content of the milk was significantly reduced in C-Sham (P < 0.01) in comparison to H-Sham and H-VSG (Figure 3A). As a percent of the total, C-Sham animals generally had increased caprylic, capric, lauric, stearic and lineoleic acid (Table 1) compared to either H-Sham or H-VSG. However, C-Sham had reduced percentages of palmitic acid and oleic acid (Table 1). There were no differences in the levels of myristic acid (Table 1). Total numbers and percentages are reported in Table 1.
Figure 3. Lipid and hormones in milk expressed from PND15/16 dams.

(A) Percent lipid composition (B) Insulin in ng/mL (C) Leptin in μg/mL (D) Adiponectin in ng/mL (E) Secretory IgA in μg/mL (F) IgG in μg/mL (G) Growth hormone in mg/mL. Data is presented as Mean ±SEM, *P < 0.05, **P < 0.01, ****P < 0.0001.
Table 1.
Data is presented as Mean ±SEM, *P < 0.05, **P < 0.01
| Fatty acid | C-Sham (A) | H-Sham (B) | H-VSG (C) | Statistics | |
|---|---|---|---|---|---|
| Caprylic acid | 8:0 | 4.311 ± 0.311 | 3.365 ± 0.109 | 2.979 ± 0.270 | A vs B, p < 0.05; A vs C, p < 0.01 |
| Capric acid | 10:0 | 12.960 ± 0.630 | 7.237 ± 0.332 | 6.901 ± 0.924 | A vs B, p < 0.001; A vs C, p < 0.001 |
| Laurie acid | 12:0 | 9.988 ± 0.534 | 4.935 ± 0.292 | 5.335 ± 0.536 | A vs B, p < 0.001; A vs C, p < 0.001 |
| Myristic acid | 14:0 | 9.204 ± 0.739 | 7.997 ± 0.334 | 8.634 ± 0.443 | |
| Palmitic acid | 16:0 | 19.330 ± 0.853 | 24.730 ± 0.333 | 26.550 ± 0.497 | A vs B, p < 0.05; A vs C, p < 0.01 |
| Stearic acid | 18:0 | 0.034 ± 0.074 | 0.006 ± 0.007 | 0.002 ± 0.003 | A vs B, p < 0.001; A vs C, p < 0.001; B vs C, p < 0.001 |
| Oleic acid | 18:1 | 13.960 ± 0.641 | 30.970 ± 0.680 | 29.390 ± 0.861 | A vs B, p < 0.001; A vs C, p < 0.001 |
| Linoleic acid | 18:2 | 23.050 ± 0.958 | 6.069 ± 0.137 | 5.429 ± 0.449 | A vs B, p < 0.001: A vs C, p < 0.001 |
Expressed as a percentage of total fat
Milk from H-Sham and H-VSG dams had increased concentrations of insulin in comparison to milk from C-Sham dams (P < 0.001) (Figure 3A). No difference in leptin concentrations were detected among the groups (Figure 3C). H-VSG had the highest concentrations of adiponectin in the milk which was significantly greater than C-Sham (P < 0.001) and H-Sham (P < 0.01) (Figure 3D). Furthermore, differences were also observed in adiponectin concentrations between C-Sham and H-Sham milk (P < 0.05) (Figure 3D). H-Sham had the lowest concentrations of IgA in comparison to C-Sham and H-VSG (P < 0.05) (Figure 3E). C-Sham had increased concentrations of IgG (P < 0.05) compared to H-Sham of H-VSG (Figure 3F). Finally, H-VSG milk had the highest concentrations of growth hormone (P < 0.05) (Figure 3G).
DISCUSSION
We previously identified that offspring of VSG dams are born smaller and shorter and continue to experience catch-up growth during postnatal life7. We hypothesized in the current work that the milk of the VSG dams was substantively different than body weight-matched and diet-matched milk from control dams. We show first that the VSG offspring have a reduced growth trajectory suggesting that perhaps the quality of the milk produced by the dam is different. Focusing on the macronutrient content, hormones and immunoglobulins we demonstrated that the milk of the VSG dam is substantively different than the diet-matched FI-Sham milk or the body weight-matched C-Sham milk.
Limited work has been done to determine the quantity and quality of milk produced by post-bariatric mothers. In one study, breast milk from normal-weight, over-weight, and obese mothers compared to post-bariatric (RYGB and lap-band) mothers measured day 1 to week 6 post-partum demonstrated that post-bariatric breast milk appears to be adequate in energy, macronutrients, and vitamin A21. Overall, the milk from the bariatric mothers, who were still considered overweight, had similar macronutrient content to the various other BMI categories of women but showed elevation in carbohydrates and proteins21. This is similar to what we report in the current study. Another study reported reduction in retinol and β-carotene in the post bariatric milk but the authors posit that the control group was not adequate and may have had other nutritional deficiencies related to demographics that reduced the quality of the breastmilk overall and diminished the ability to observe differences in the post-bariatric milk22.
Variation in milk composition.
Macronutrient composition differs when comparing preterm to term milk, with preterm milk being higher in protein and fat23. However, despite the complex variation in maternal nutritional status, macronutrient composition is still often conserved23. In our studies, the VSG dams not only have altered nutritional status but a completely altered physiology; hence, we observe some unique differences in the milk from the VSG dams.
Proteins.
The most abundant proteins in breast milk are casein, α-lactalbumin, lactoferrin, secretory immunoglobulin IgA, lysozyme, and serum albumin24. Although milk protein concentration is not widely affected by the diet of the mother, protein concentration is reduced with increased maternal body weight25,26. Milk protein can also be reduced in mothers who produce greater volumes of milk potentially due to dilution of the concentration of protein23. In our current study, the lowest milk albumin levels are in the H-Sham dams which weighed the greatest amount. The C-Sham and H-VSG, which generally had similar body weights, had equivalent concentrations of milk protein. These data are congruent with our previous studies where there were minimal amino acid differences between sham and VSG rats7. By all indications, protein content appears adequate which was previously published in the post-bariatric human milk study21.
Lipids in milk.
Triglycerides account for 98% of the fats in milk. Therefore, maternal diet and thus, circulating plasma levels of triglycerides increase the availability of triglycerides for production of milk. In the current study, total triglyceride levels in VSG milk were significantly reduced in comparison to either C-Sham or H-Sham. This is not surprising; post-VSG rats have significantly reduced circulating fasting plasma triglyceride levels27 which are further reduced during VSG pregnancy7. Cholesterol makes up only 0.3% of milk fat content and in our studies, we did not observe altered cholesterol levels in VSG milk. In general, the fatty acid composition of the milk was affected by the diet of the dam rather than the surgery of the dam or body weight of the dam. Both H-Sham and H-VSG animals were maintained on a 41 % saturated fat diet derived from butter-fat whereas the chow diet had 5.67% saturated fat content derived from soybean oil. Therefore, the overall percentage of lipid and the type of the free fatty acid that appears in the milk is influenced by what is consumed by the dam and not by the metabolic status (i.e. level of adiposity) of the rat. The greater the fat intake of the dam, the greater the percentage of the large long-chain fatty acids. Our data support that the HFD-fed animals had significantly elevated levels of C:14-18 long-chain fatty acid levels in comparison to chow-fed C-Shams. Accordingly, this resulted in significant reduction of the short-chain fatty acid concentrations of milk samples in the H-Sham and H-VSG dams (C:8-10). De novo fatty acid synthesis in the mammary gland is reduced when more long chain fatty acids are available in the diet. Taken together, the milk of the VSG provides a significant proportion of its caloric content in the form of fatty acids; in general, this is a function of the diet consumed by the dam and this level of fat content appears to not be altered by the surgical intervention of the dam. It is unfortunate that at the time the collection of these samples, we were not able to obtain samples from VSG rats that were maintained on chow since we were not generating these animals at the time of the milk collection. Future research should examine this cohort.
Variations in hormonal-regulators of appetite in breast milk.
With respect to hormones expressed naturally in breast milk, it is unknown as to their role in programming health and disease in the offspring. Insulin measured in breast milk is often negatively correlated with body weight, thus the highest levels of insulin were associated with lower infant body weight when relatively normal-weight mother-infant pairs were investigated28. However, in other studies by the same group, when insulin levels in breast milk were compared in mothers that had obese or lean BMI’s, the highest insulin levels were obtained from obese mothers29. Again, this is mimicked in our data. The lowest levels of insulin were measured in milk from lean C-Shams. H-Sham dams had significantly higher levels of insulin, but the VSG dams which had lower levels of adiposity produced significantly higher levels of insulin and had the smallest pups29.
Leptin concentrations in breast milk typically correlate positively with maternal plasma leptin concentrations and with maternal BMI30. However, the relationship between leptin levels measured in milk and infant body weight outcomes are varied. Various studies have either shown significant correlation between higher maternal BMI and higher milk leptin levels, but the milk leptin levels at 1 month correlated inversely with infant adiposity and length at 6 months29,30. This potentially suggests that leptin or similar anorexic hormones produced in milk might modulate the subsequent growth of the offspring. However, another study reported no significant difference between milk leptin concentrations of obese and non-obese’ mothers31, even though breast milk leptin concentrations were significantly correlated with mothers’ BMI31. Another study comparing leptin levels from breastmilk from overweight vs. normal-weight mothers demonstrated that leptin levels were not predictive of the growth or body weight of the babies throughout infancy32. No consensus exists concerning the relationship of leptin. In the current study leptin levels do not reflect the body weight differences of the dams at the time of the milk collection or their weight prior to pregnancy7.
Adiponectin is an adipocyte-derived hormone important in regulating plasma glucose and fatty acids. For both men and women, adiponectin has been shown to have a moderately negative correlation with BMI, percent body fat, sum of skin folds, waist circumference, fasting triglycerides and plasma insulin and leptin33. There are two forms of adiponectin: high and low molecular weight versions; in human milk, adiponectin is invariably the high molecular weight version. Adiponectin levels measured in milk from both obese and normal-weight mothers show a significant negative correlation between milk adiponectin and the weight of the 4 month old obese infants32. Another study reported that lower infant weights were associated with higher milk adiponectin34. In our present work, the most profound difference we observed in the milk was in the levels of adiponectin where H-VSG had the highest levels of adiponectin. Since circulating plasma adiponectin varies inversely with adiposity, it is not surprising that VSG have the highest amount of milk adiponectin,7,35 however it is interesting that C-Sham dams produce the lowest levels of adiponectin in milk despite having lower levels of adiposity compared to H-Sham in every study that we have performed7,35. In a study of maternal milk collected at 6 weeks postpartum, adiponectin levels were predictive for being overweight at 24 months of age; high milk adiponectin levels were thus a risk factor for overweight offspring later in life36. This is intriguing with the current VSG model since the highest adiponectin in milk is from H-VSG dams who we have shown give rise to adult pups with greater adiposity than either the C-Sham or H-Sham7.
Growth hormone is also secreted into maternal milk and when the mother is supplemented with exogenous growth hormone, can increase the rate of growth of her offspring. Here we report that growth hormone in VSG milk is elevated. This may be a compensation for the low growth hormone produced within the dam (unpublished data) as a result of overall low total and active ghrelin levels7 due to 80% resection of the stomach following bariatric surgery. Increases in growth hormone may help to produce “catch-up” growth that the VSG pups require because of their reduced birth weight and growth trajectory.
Milk Immunoglobulins provide immune protection.
The most common immunoglobulin in milk is secretory IgA though the other immunoglobulins (IgG and IgM) are also present. IgG is the only immunoglobulin that is able to pass free from the mother to the infant and maternal immune health is transferred to the infant via immunoglobulins in the maternal milk. Typically, infants are born with low IgA and this is increases as the infant ages and is augmented through maternal milk. In a study that collected colostrum from lean, overweight and obese mothers, IgA levels were higher in colostrum obtained from obese women37. In our study, we did not collect colostrum but rather mature milk. No differences were reported in this study in IgM or IgG levels37. In our rodent study, the obese H-Sham have the lower levels of IgA and the highest levels of IgG were observed in the C-Sham rats. The lowest levels of IgG in milk were measured in the H-VSG animals. This is in direct contrast to the high levels of IgG that were measured in plasma at G19 during pregnancy35. It is possible that the IgGs in milk are depleted during early postnatal life or alternatively that IgGs do not pass normally to the infant through the placenta after VSG pregnancy.
Caveats and limitations to the current work.
In the present study, a significant limitation of the study is the lack of a fourth group of dams that received VSG and then were maintained on chow after their surgery. This particular group would have strengthened our ability to parse out differences attributable to both surgery and diet. Also study we were not able to quantify the relative amount of milk produced by the dams to feed their pups. This could have been accomplished through a weigh-suckle-weigh paradigm. This paradigm can be somewhat disruptive to maternal behavior and we were not able to carry this out in the present cohort. Thus, it is possible that VSG dams were not able to produce the same quantity of milk as the sham dams. Furthermore, it is possible that the water content of the milk was altered in VSG dams’ milk which we were not able to account for. Reduced capacity for milk could also result in reduced growth trajectory for the pups during postnatal life and would further reduce their ability to thrive. We also only chose one time point to measure concentrations of analytes within the milk. It would have been useful if we had collected colostrum since milk solids decrease substantially with the formation of mature milk. Furthermore, directly assaying fat-soluble vitamins in the milk would also have strengthened this study considering the impact on lipids of VSG. We also did not study and report maternal behavior patterns and the overall length of time that the dams spent suckling their young. Some cursory observations suggest that VSG dams do not spend as much time caring for their pups as Sham dams but this would need to be studied in a controlled paradigm to define the ways in which VSG offspring may be affected by this altered maternal behavior35.
Conclusions.
Overall, there appears to be a shift in the caloric content of VSG milk such that total calories from fat are reduced and total calories from glucose may be increased thus overall producing milk with a reduced caloric content for the VSG offspring. The VSG offspring from dams maintained on HFD during pregnancy are born small-for-gestational age and also have a reduced growth trajectory requiring catch-up growth during postnatal life. This pre-clinical work is important to further support women seeking to improve their reproductive potential by obtaining bariatric surgery. Further work is necessary in humans who have received VSG or other bariatric procedures to determine if similarities in milk content are observed and whether macro- and micronutrient supplementation is advisable.
Acknowledgements
Financial Support
E.M.D is supported by T32 HL105324. B.E.G has received funding from the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number P20GM121334; Mississippi Center of Excellence in Perinatal Research (MSCEPR) COBRE. L.L.H is supported by USDA grants Hatch WIS01732 and NIFA: 2016-67015-24584 and by NICHD: R01HD094759. Analytical and Assay Core at UMMC performed some work supported by Award Number P20GM104357 and HL51971. Plasma assays were completed by the Mouse Metabolic Phenotyping Center at the University of Cincinnati, Ohio (www.uc.edu/labs/mmpc.html) funded by U2C DK059630. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Footnotes
Conflicts of Interest
E.M.D, L.LH, B.W. and B.E.G have no conflicts of interest to declare. R.J.S receives research support from Ethicon Endo-Surgery/Johnson & Johnson, Novo Nordisk, Zafgen, Kallyope and MedImmune. He has equity in Zafgen. R.J.S. also acts as a consultant for Ethicon Endo-Surgery/Johnson & Johnson, Novo Nordisk, Sanofi, Janssen/Johnson & Johnson, Kallyope and Scohia.
Ethical Standards
The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guides on the care and use of laboratory animals, IACUC and has been approved by the institutional committee at the University of Cincinnati.
REFERENCES
- 1.Colquitt JL, Pickett K, Loveman E & Frampton GK Surgery for weight loss in adults. The Cochrane database of systematic reviews 8, Cd003641, doi: 10.1002/14651858.CD003641.pub4 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Himpens J, Dobbeleir J & Peeters G Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252, 319–324 (2010). [DOI] [PubMed] [Google Scholar]
- 3.Peterli R, Wölnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, … & Beglinger C Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Annals of surgery 250, 234–241 (2009). [DOI] [PubMed] [Google Scholar]
- 4.Chambers AP, Jessen L, Ryan KK, Sisley S, Wilson–Pérez HE, Stefater MA, … & D’Alessio DA . Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. . Gastroenterology 141, 950–958 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, … & Bhatt DL . Bariatric surgery versus intensive medical therapy in obese patients with diabetes. . New England Journal of Medicine 366, 1567–1576 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Stemmer K, Bielohuby M, Grayson BE, Begg DP, Chambers AP, Neff C, Woods SC, Erben RG, Tschöp MH, Bidlingmaier M, Clemens TL, … Seeley RJ . Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. . Endocrinology 154, 2015–2024 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Grayson BE, Schneider KM, Woods SC & Seeley RJ Improved rodent maternal metabolism but reduced intrauterine growth after vertical sleeve gastrectomy. Sci Transl Med 5, 199ra112, doi: 10.1126/scitranslmed.3006505 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Teitelman M, Grotegut C, Williams N & Lewis J The Impact of Bariatric Surgery on Menstrual Patterns. Obesity Surgery 16, 1457 (2006). [DOI] [PubMed] [Google Scholar]
- 9.Rochester D et al. Partial recovery of luteal function after bariatric surgery in obese women. Fertility and Sterility 92, 1410 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tan O & Carr BR The impact of bariatric surgery on obesity-related infertility and in vitro fertilization outcomes. Seminars in reproductive medicine 30, 517–528, doi: 10.1055/s-0032-1328880 (2012). [DOI] [PubMed] [Google Scholar]
- 11.Johansson K et al. Outcomes of pregnancy after bariatric surgery. The New England journal of medicine 372, 814–824, doi: 10.1056/NEJMoa1405789 (2015). [DOI] [PubMed] [Google Scholar]
- 12.Galazis N, Docheva N, Simillis C & Nicolaides KH Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis. European journal of obstetrics, gynecology, and reproductive biology 181, 45–53, doi: 10.1016/j.ejogrb.2014.07.015 (2014). [DOI] [PubMed] [Google Scholar]
- 13.Parker MH, Berghella V & Nijjar JB Bariatric surgery and associated adverse pregnancy outcomes among obese women. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet, 1–4, doi: 10.3109/14767058.2015.1060214 (2015). [DOI] [PubMed] [Google Scholar]
- 14.Baker RW, Osman J & Bodnar RJ Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet. Pharmacol Biochem Behav 69, 201–208. (2001). [DOI] [PubMed] [Google Scholar]
- 15.Gonzalez I et al. Maternal and perinatal outcomes after bariatric surgery: a Spanish multicenter study. Obes Surg 25, 436–442, doi: 10.1007/s11695-014-1387-7 (2015). [DOI] [PubMed] [Google Scholar]
- 16.Chambers AP et al. Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in Rats. Gastroenterology 141, 950–958 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Stefater M et al. Sleeve Gastrectomy Induces Loss of Weight and Fat Mass in Obese Rats, But Does Not Affect Leptin Sensitivity. Gastroenterology 138, 2426–2436 e2423 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wilson-Perez HE et al. The effect of vertical sleeve gastrectomy on food choice in rats. International journal of obesity (2005) (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Parlee SD, & MacDougald OA (Maternal nutrition and risk of obesity in offspring: the Trojan horse of developmental plasticity. . Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842, 495–506 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lactation, I. o. M. U. C. o. N. S. D. P. a. Nutrition During Lactation. . Washington (DC): National Academies Press (US) Milk; Volume 5 (1991). [Google Scholar]
- 21.Ameye L et al. Bariatric Surgery Does Not Appear to Affect Women’s Breast-Milk Composition. The Journal of nutrition 148, 1096–1102, doi: 10.1093/jn/nxy085 (2018). [DOI] [PubMed] [Google Scholar]
- 22.Garretto D et al. Vitamin A and beta-carotene in pregnant and breastfeeding post-bariatric women in an urban population. Journal of perinatal medicine 47, 183–189, doi: 10.1515/jpm-2018-0142 (2019). [DOI] [PubMed] [Google Scholar]
- 23.Ballard O, & Morrow AL . Human milk composition: nutrients and bioactive factors. Pediatric Clinics 60, 49–74 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lönnerdal B Nutritional and physiologic significance of human milk proteins. The American journal of clinical nutrition 77, 1537S–1543S (2003). [DOI] [PubMed] [Google Scholar]
- 25.Bachour P, Yafawi R, Jaber F, Choueiri E & Abdel-Razzak Z Effects of Smoking, Mother’s Age, Body Mass Index, and Parity Number on Lipid, Protein, and Secretory Immunoglobulin A Concentrations of Human Milk. Breastfeeding Medicine 7, 179–188, doi: 10.1089/bfm.2011.0038 (2011). [DOI] [PubMed] [Google Scholar]
- 26.Rolls BA, Gurr MI, Van Duijvenvoorde PM, Rolls BJ & Rowe EA Lactation in lean and obese rats: Effect of cafeteria feeding and of dietary obesity on milk composition. Physiology & Behavior 38, 185–190, doi: 10.1016/0031-9384(86)90153-8 (1986). [DOI] [PubMed] [Google Scholar]
- 27.Grayson BE et al. Bariatric surgery emphasizes biological sex differences in rodent hepatic lipid handling. Biology of sex differences 8, 4, doi: 10.1186/s13293-017-0126-x (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Fields DA & Demerath EW Relationship of insulin, glucose, leptin, IL-6 and TNF-alpha in human breast milk with infant growth and body composition. Pediatric obesity 7, 304–312, doi: 10.1111/j.2047-6310.2012.00059.x (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Fields DA et al. Associations between human breast milk hormones and adipocytokines and infant growth and body composition in the first 6 months of life. Pediatric obesity 12 Suppl 1, 78–85, doi: 10.1111/ijpo.12182 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Miralles O, Sánchez J, Palou A & Picó C A Physiological Role of Breast Milk Leptin in Body Weight Control in Developing Infants. Obesity 14, 1371–1377, doi: 10.1038/oby.2006.155 (2006). [DOI] [PubMed] [Google Scholar]
- 31.Uysal FK et al. Breast milk leptin: its relationship to maternal and infant adiposity. Clin Nutr 21, 157–160, doi: 10.1054/clnu.2001.0525 (2002). [DOI] [PubMed] [Google Scholar]
- 32.Khodabakhshi A et al. Comparative measurement of ghrelin, leptin, adiponectin, EGF and IGF-1 in breast milk of mothers with overweight/obese and normal-weight infants. European journal of clinical nutrition 69, 614–618, doi: 10.1038/ejcn.2014.205 (2015). [DOI] [PubMed] [Google Scholar]
- 33.Goropashnaya AV, Herron J, Sexton M, Havel PJ, Stanhope KL, Plaetke R, … & Boyer BB Relationships between plasma adiponectin and body fat distribution, insulin sensitivity, and plasma lipoproteins in Alaskan Yup’ik Eskimos: the Center for Alaska Native Health Research study Metabolism: clinical and experimental 58, 22–29 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Woo JG et al. Human milk adiponectin is associated with infant growth in two independent cohorts. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 4, 101–109, doi: 10.1089/bfm.2008.0137 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Spann RA et al. Rodent vertical sleeve gastrectomy alters maternal immune health and fetoplacental development. Clin Sci (Lond) 132, 295–312, doi: 10.1042/CS20171416 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Weyermann M, Brenner H & Rothenbacher D Adipokines in Human Milk and Risk of Overweight in Early Childhood: A Prospective Cohort Study. Epidemiology 18, 722–729, doi: 10.1097/EDE.0b013e3181567ed4 (2007). [DOI] [PubMed] [Google Scholar]
- 37.Fujimori M et al. Changes in the biochemical and immunological components of serum and colostrum of overweight and obese mothers. BMC pregnancy and childbirth 15, 166, doi: 10.1186/s12884-015-0574-4 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
